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Abstract
Background: Influenza viruses can modulate and hijack several cellular signalling pathways to efficiently support
their replication. We recently investigated and compared the cellular gene expression profiles of human lung A549
cells infected by five different subtypes of human and avian influenza viruses (Josset et al. Plos One 2010). Using
these transcriptomic data, we have focused our analysis on the modulation of the p53 pathway in response to
influenza infection.
Results: Our results were supported by both RT-qPCR and western blot analyses and reveal multiple alterations of
the p53 pathway during infection. A down-regulation of mRNA expression was observed for the main regulators of
p53 protein stability during infection by the complete set of viruses tested, and a significant decrease in p53 mRNA
expression was also observed in H5N1 infected cells. In addition, several p53 target genes were also down-
regulated by these influenza viruses and the expression of their product reduced.
Conclusions: Our data reveal that influenza viruses cause an overall down-regulation of the host p53 pathway and
highlight this pathway and p53 protein itself as important viral targets in the altering of apoptotic processes and in
cell-cycle regulation.
Background
Influenza viruses belong to the Orthomyxoviridae family
of enveloped viruses containing a segmented genome of
single stranded negative RNA. Among the three influ-
enza types (A, B and C), type A is the most virulent
pathogen with a diversity represented by the combina-
tion of 16 H and 9 N different subtypes (e.g. H1N1,
H5N1) [1]. Influenza A viruses are the most serious
threat to public health, with the potential to cause glo-
bal pandemics as was illustrated in 2009 with the emer-
gence of H1N1 SOIV [2].
All known subtypes of the influenza A virus are main-
tained in wild waterfowl, the natural reservoir of these
viruses [3]. Current human circulating influenza A
subtypes are H1N1 and H3N2. While extensive viral
diversity is responsible for the subtype-specific virus-host
interactions, many common functional features are also
shared among viruses. Influenza infection alters host cel-
lular homeostasis via the combination of the virally-
induced alteration of biological machineries/pathways and
the cellular antiviral response triggered by intracellular
signalling cascades. Influenza viruses are able to activate/
inhibit and hijack several cellular signalling pathways to
efficiently support their own replication [4].
The development of high-throughput ‘omic’ studies
has increased our understanding of viral-host interac-
tions. Numerous studies have described host gene
expression modifications induced upon viral infection
in vitro, in animal models and in patients [5-9]. For exam-
p l e ,ag l o b a lm R N Ap r o f i l i n gs t u d yo fM D C K - i n f e c t e d
cells has revealed an important role of the NF-kappaB
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extent for the currently circulating H3N2 strain [10].
Other intracellular signalling cascades are also induced by
infection, in particular the mitogen-activated protein
kinase (MAPK) and the PI3K/Akt pathways, both of which
activate downstream transcription factors thereby affecting
host gene expression [11,12]. While a small number of
transcriptional studies have compared the cellular
response induced by infection with highly pathogenic
strains such as H1N1 1918 and H5N1 to that induced
with low pathogenic strains, a systematic analysis and
comparison of host cell mRNA expression during infec-
tion by several genetically diverging influenza subtypes has
not yet been performed [7,8,13,14].
Using a nylon microarray, we recently characterized
common gene expression changes induced during the
infection of human lung epithelial cells by five different
influenza A viruses. This shared signature was exploited
to find new molecules that act on host metabolic path-
ways to bring about an antiviral effect against several
subtypes [15]. Moreover, our systematic transcriptomic
study also provided a gene expression database with
which we compared the cellular responses induced by
different influenza viruses. In the present study, we used
the same data set to analyze strain specificity in regard
to several host pathways. We observed that each viral
signature was mainly associated with cellular pathways
linked to cell death and cell cycle progression (i.e. cell
growth). At the crossroads of all of these cellular pro-
cesses, the p53 pathway became the focus of our investi-
gation. Our analyses, validated by both RT-qPCR and
western blot analyses, reveal multiple alterations within
the p53 pathway during influenza A infection.
Methods
Cell lines, viruses and infection
Human lung epithelial A549 cells (ATCC CCL-185) or
human colon carcinoma HCT116 cell lines were grown as
monolayers in Dulbecco’s modified Eagle’sm e d i u m
(DMEM, Gibco), supplemented with 10% heat-inactivated
foetal bovine serum, 2 mM L-glutamine, 100 U/mL of
penicillin and 100 mg/mL of streptomycin sulphate, at
37°C. The HCT116 cell lines containing a p53 wild-type
(p53+/+) and a p53-deleted derivative (p53-/-) were
gifts from Dr. Bert Vogelstein (John Hopkins University,
Baltimore, MD, USA) [16]. Influenza viruses A/New Cale-
donia/20/99 (H1N1), A/Moscow/10/99 (H3N2), A/Lyon/
969/09 (H1N1 SOIV), A/Turkey/582/2006 (H5N1),
A/Finch/England/2051/94 (H5N2), and A/Chicken/Italy/
2076/99 (H7N1) were produced in MDCK cells in EMEM
supplemented with 2 mM L-glutamine, 100 U/mL of peni-
cillin, 100 mg/mL of streptomycin sulphate and 1 mg/mL
of trypsin. Viruses were titrated to determine the 50%
tissue culture infective dose (TCID50) in MDCK cells as
described in our previous study [17]. Confluent A549 cells
were infected with influenza viruses at a MOI of 1 or 10-3
for one hour in a minimal volume of DMEM supplemen-
ted with 2 mM L-glutamine, 100 U of penicillin/mL,
100 μg of streptomycin sulphate/mL and 0.5 μg of trypsin/
mL (infection medium) at 37°C. The cells were then over-
laid with fresh infection medium and incubated at 37°C
for 24 h. Viral kinetics for the six different influenza
viruses have been determined previously [15]. No markers
of apoptosis were detected at 24h post infection (MOI 1)
by western blot (capspase 3 cleavage) and no signs of cell
death were observed (data not shown).
Microarray analysis
Gene expression data of A549 cells infected by H1N1,
H3N2, H5N1, H5N2 or H7N1 influenza viruses or
mock infected (five replicates in each group) were
obtained in our previous study [15]. Data sets are avail-
able publicly from the Gene Expression Omnibus (GEO)
database (http://www.ncbi.nlm.nih.gov/geo/) under
accession number GSE22319. Five supervised analyses
between groups of infected versus mock samples were
conducted using the Significance Analysis of Microarray
algorithm (SAM) [18], and the siggenes library (v1.18.0)
[19]. Ingenuity Pathway Analysis 5.0 (IPA) (Ingenuity
Systems, Redwood City, CA, USA) was used to select,
annotate, and visualize genes according to function and
pathway (Gene Ontology). Additional gene annotation
was provided by the Interferome Database [20] and
DAVID database (http://david.abcc.ncifcrf.gov/). Heat
maps were produced by the heat map function from R
that uses hierarchical clustering with Euclidean distance
metric and the complete linkage method to generate the
hierarchical tree (http://www.r-project.org/).
Validation by RT-qPCR
Total RNAs were extracted using the RNAeasy Mini Kit
(Qiagen). Reverse-transcription was performed on 1 μg
of total RNAs using the Superscript II enzyme (Invitro-
gen) at 42°C. Quantification of the level of different
mRNAs of interest was performed by real-time PCR on
a MX3005P apparatus (Stratagene). Briefly, 20 ng of
cDNAs were amplified using 0.8 μM of each primer,
0.4 μM of probe (cf. Table 1) and 1X Taqman Universal
Master Mix (Applied Biosystems). All data were normal-
ized to the internal standard Actin. For each single-well
amplification reaction, a threshold cycle (Ct) was
observed in the exponential phase of amplification. Rela-
tive changes in gene expression were determined using
the 2ΔΔCt method and reported as the n-fold difference
relative to a control cDNA (mock, uninfected cells) pre-
pared in parallel with the experimental cDNAs (infected
cells) [21]. The mRNA levels were measured in triplicate
in two independent experiments. Quantification of M
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formed according to previously published work [22].
Western blot analysis
Total proteins were extracted by scraping and syringing
cells in 1X NuPAGE LDS buffer (Invitrogen). Fifteen to
thirteen micrograms of total proteins were then sepa-
rated on pre-cast 10% NuPAGE gels (Invitrogen). To
detect the different proteins of interest, the following
antibodies were used: mouse monoclonal DO-1 (p53)
and SX118 (p21, Cell signalling), Rabbit polyclonals Bax,
Akt and Bcl-XL (Cell signaling). The mouse monoclonal
Ku80 antibody was used as a loading control (Abcam).
The relative protein levels (RPL) were calculated by den-
sitometry analysis performed with the help of the ImageJ
software (http://rsbweb.nih.gov/ij/).
Results
Specific viral signatures and commonly targeted host
genes
We have previously reported variations in gene expres-
sion at 24 h post-infection in human pulmonary epithe-
lial A549 cells infected with different subtypes of
influenza viruses: human A/New Caledonia/20/99
(H1N1), A/Moscow/10/99 (H3N2), avian A/Turkey/582/
2006 (H5N1), A/Finch/England/2051/94 (H5N2), A/
Chicken/Italy/2076/99 (H7N1) influenza viral strains or
mock control infection (five replicates in each group)
[15]. Compared to the mock control infection, changes
were observed in 36 cellular genes for H1N1, 2298
genes for H3N2, 1455 genes for H5N1, 1510 genes for
H5N2 and 3020 genes for H7N1 (SAM algorithm with a
False Discovery Rate of 10%). The small changes
induced upon H1N1 infection were correlated to its low
level of replication in our experimental conditions [15].
While 83% of the host genes altered following H1N1
infection were over-expressed, a similar number of
genes were over- and under-expressed for each of the
other viruses (figure 1A). Furthermore, we found that
the expression levels for a total of 300 genes (represent-
ing 3.4% of the genes considered present on the chip)
differed significantly between mock and all infected
samples including H1N1 [15].
To determine the specific cellular genes showing
a l t e r e de x p r e s s i o nw i t h i ne a c ho ft h ed i f f e r e n ts t r a i n -
specific signatures, we built the Venn diagram shown in
figure 1B. Common changes in the expression of
numerous genes (1007) were induced by three of the
viruses, H3N2, H5N2 and H7N1. The expression of 705
of these genes was also altered when four viruses were
considered: H3N2, H5N1, H5N2 and H7N1. Since
H1N1 deregulated only a small number of genes, the
number of those the expression of which was modified
by all strains was limited to 20. Their associated biologi-
cal responses were described in our previous study and
are mainly linked to the immune response in accor-
dance with other investigations [15].
Biological processes associated with each viral signature
We then determined the Gene Ontology (GO) biological
processes (or terms) significantly associated with each
viral signature using the DAVID database. With a
Table 1 List of primers used in this study
Primers & probes Sequence 5’-3’
p53 (Exon8-9) Forward GAA GAG AAT CTC CGC AAG AAA GG
Reverse TCC ATC CAG TGG TTT CTT CTT TG
Probe AGC ACT AAG CGA GCA CTG CCC AAC
p21 Forward GACTCTCAGGGTCGAAAACGG
Reverse GCGGATTAGGGCTTCCTCTT
Probe CTACCACTCCAAACGCCGGCTGATCT
Bax Forward ACTCCCCCCGAGAGGTCTT
Reverse GCAAAGTAGAAAAGGGCGACAA
Probe GAGCTGACATGTTTTCTGACGGCAACTTCAACT
Bcl-XL Forward TCC TTG TCT AGG CTT TCC ACG
Reverse GGT CGC ATT CTC GCC TTT
Probe ACA GTG CCC CGC CGA AGG AGA
Influenza M Forward CTTCTAACCGAGGTCGAAACGTA
Reverse GGTGACAGGATTGGTCTTGTCTTTA
Probe TCAGGCCCCCTCAAAGCCGAG
Figure 1 Summary of genes expressed in response to H1N1,
H3N2, H5N1, H5N2 and H7N1 viral infection. A. Genes
significantly regulated (SAM, FDR = 10%) in response to the
different influenza viruses compared to mock infection at 24 hpi are
shown. B. Venn-diagram showing the genes co-regulated by several
viruses
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viruses. The 36 genes deregulated upon H1N1 infection
encode proteins involved in the cellular immune
response, transcription, biogenesis of protein complexes
and nucleic acid metabolic processes. In contrast, the
signatures of H3N2, H5N1, H5N2 and H7N1 viruses
were each associated with 33 common terms (p-value
< 0.01) (figure 2), covering all the biological processes of
DAVID database. Two major classes of biological pro-
cesses could be distinguished. Firstly, there are those
that are affected by the four viral strains through the
modulation of a common gene subset. For example,
each of the viral strains modulated the expression of 10
common genes involved in the glucose catabolic pro-
cess”, while only a few genes involved in this process
were differentially modulated in a strain-dependent
manner. Secondly, there are those that are affected by
each of the four viral strains through the modulation of
distinct gene subsets in a strain-dependent manner. For
example, while 35 genes all associated with the “apopto-
sis” process were modulated by the four viruses, 11 of
these were specifically modified upon H3N2 infection,
11 by H5N1, 7 by H5N2 and 35 by H7N1.
Among the 33 common terms associated with the
viral signatures, more than 60% (n = 20) were related to
the control of cell death or cell cycle progression. Other
common biological processes were related to angiogen-
esis, protein complex biogenesis or metabolism [15].
Interestingly, despite the abovementioned current asso-
ciation made between influenza virus-induced host cell
responses and the cellular immune response, we found
no terms shared by all viruses relating to the immune
response. Moreover, by consulting the whole list of bio-
logical processes associated to each virus signature we
found the term “immune response” significantly mapped
to each viral profile, except for the H5N2 virus. How-
ever, the comparison of our differentially expressed gene
lists to Interferome, an IFN-regulated gene database,
revealed that a similar proportion of genes regulated
upon infection by H3N2, H5N1, H5N2 or H7N1
(around 15%) was related to the IFN response, whereas
48% of the genes responding to H1N1 infection were
regulated by IFN [20].
In summary, analysis of our data showed that more
than half of the genes responding to infection by H3N2,
H5N1, H5N2 and H7N1 viruses, are involved in cell
death, cell cycle progression or the cellular immune
response. All these biological processes are regulated by
a central signalling pathway, the p53 pathway [23].
Indeed, in addition to regulating the expression of genes
involved in apoptosis and cell cycle arrest, p53 also reg-
ulates the expression of type I IFN as well as several
genes carrying IFN-stimulated response elements [24].
For these reasons, and in light of several proposals of
p53 being a functional interactant of influenza [25-27],
we focused our investigations on modifications of the
p53 pathway in response to influenza infection.
Infection induces a transcriptional down-regulation of the
upstream signal part of the p53 pathway
In response to stress, such as viral infection, several sig-
nalling mediators relay the stress stimuli to the p53
Figure 2 Significantly enriched GO Biological Processes (p-value < 0.01) common to H3N2, H5N1, H5N2 and H7N1 specific signatures.
Terms related to the p53 pathway are highlighted in grey.
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mainly by post-translational modifications including
phosphorylations and acetylations [28]. Such modifica-
tions disrupt interactions between p53 and the ubiquitin
ligase Hdm2, responsible for the rapid degradation of
p53 in basal conditions [29,30]. Once activated, p53 reg-
ulates cell cycle arrest and apoptosis through the direct
modulation of host cellular gene expression.
We firstly focused our attention on the upstream sig-
nal part of the p53 pathway. According to our data, all
the main kinases known to directly regulate p53 phos-
phorylation status (DNA-PK, Chk2, JNK1 and Gsk3b)
are under-expressed following infection by H3N2,
H5N1, H5N2 and H7N1 viruses (figure 3). For example,
n-fold DNA-PK mRNA changes of -1.78, -2.12, -1.41
and -1.56 were measured for H3N2, H5N1, H5N2 and
H7N1, respectively (figure 3). We also focused our
attention on the phosphatidylinositol 3-kinase (PI3K)/
Akt pathway, which directly regulates Hdm2 expression
and thus endogenous p53 activity [31]. Interestingly, our
results indicate a decreased expression of both AKT1
and its negative regulator PTEN (figure 3). These results
are in accordance with the activation of the phosphatidy-
linositol 3-kinase (PI3K)/Akt pathway during influenza
infection, as already described in the literature [32].
Altogether, our results reveal that influenza A infection
induces the transcriptional down-regulation of several
genes encoding host factors belonging to the upstream
signal part of the p53 pathway and which act on the
endogenous activity of p53.
Differential effects of influenza viruses on p53 mRNA and
protein levels
Secondly, we assessed whether viral infection could also
directly affect p53 mRNA expression. Interestingly, our
data indicates that only one of the investigated viruses,
H5N1, led to a significant decrease in the level of p53
mRNA expression, with a fold change of -1.54 (figure 3).
Figure 3 Transcriptional regulation of the genes belonging to the p53 signalling pathway (IPA canonical pathway) during influenza
viral infection. Mean fold changes of the genes encoding regulators and targets of p53 that were differentially expressed by at least one virus,
calculated as Log2(Mean expression levels in infected samples) - Log2(Mean expression levels in mock samples) and overlaid on the pathway in
green for downregulated genes (FC < 0), and red for upregulated genes (FC > 0). Fold changes in each group of samples are depicted in the
heat maps and were used to cluster hierarchically both samples and genes. Genes considered significant for each virus with the SAM procedure
are indicated by a white X on the heat maps.
Terrier et al. Virology Journal 2011, 8:285
http://www.virologyj.com/content/8/1/285
Page 5 of 11To assess such differential data, we infected another set
of A549 cells with the different viruses used in our initial
microarray study, including the low replicative H1N1
virus to which we added the recent pandemic H1N1
SOIV as an efficient productive H1N1 virus [28]. Total
cell RNA was extracted 24 hours post-infection, similarly
to that performed for the microarray analysis. The quan-
tification of p53 mRNA levels was carried out by RT-
qPCR using primers matching several different EST
sequences used in the microarray chip. In accordance
with our previous data, no significant change in the p53
mRNA ratio was detected with H3N2, H5N2 and H7N1,
nor with H1N1 or H1N1 SOIV, while a significant ratio
change of 0.70 was observed in H5N1 infected cells (p <
0.0005, figure 4A). The calculated fold change was -1.43,
indicating the specific down-regulation of p53 mRNA
expression in the context of H5N1 infection.
We further investigated whether such influenza-
induced variations in p53 mRNA levels could be corre-
lated or not with changes in the endogenous p53
protein level. For that, we reproduced the same experi-
mental conditions as described above and performed
western blots on infected cellular extracts. Compared to
mock-infected cells, the p53 protein levels (Relative
Protein Level, RPL) measured by densitometry analysis
were significantly increased in cells infected by all the
viruses studied, with a 1.78 to 2.72 fold increase for
respectively H7N1 and H1N1 (SOIV), and a smaller
1.22 fold increase for H5N1 (figure 4B and 4C).
Our data further support the previously reported non-
correlation between p53 mRNA and protein levels in
response to influenza infection, and are also in line with
several other investigations reporting such a mismatch
in the context of other cellular stresses [33]. Moreover,
our results reveal an interesting contrast between H5N1
and the other viruses. Indeed, H5N1 infection directly
affects the p53 mRNA expression level, accounting for
the attenuated increase in the p53 protein level observed
in the H5N1 infected cell.
Transcriptional down-regulation of downstream signalling
of the p53 pathway upon infection
Having determined an increase in p53 protein levels
during the time-course of infection, we then focused
our attention on the expression of p53 downstream tar-
get genes. While several studies have previously shown
an increase in p53 transcriptional activity during influ-
enza virus infection by luciferase assay or the detection
of phosphorylated p53 in infected cells [25,34], we
observed in our experimental conditions a significant
decrease in the transcriptional expression of several
p53-targets genes during infection by H3N2, H5N1,
H5N2 and H7N1 viruses (figure 3). These down-regu-
lated genes include p21, 14-3-3, PERP, FAS, DR4/5,
PIG3, BAX, Bcl-XL, PAI-1 and PCNA. For p21
(CDKN1A) for example, the n-fold mRNA changes mea-
sured were -1.81, -2.0 and -1.85 for H3N2, H5N1 and
H7N1 infections, respectively. The expression of only
two p53-target genes investigated, Teap (TP53INP1),
and GADD45G was increased upon infection by the 4
viruses (figure 3). The GADD45G n-fold mRNA changes
measured were 1.61, 1.70, 1.26 and 1.60 for H3N2,
H5N1, H5N2 and H7N1, respectively. It should be
noted that TP53INP1 is also known to be regulated by
p73, a p53 homologous protein, and must therefore be
also regulated in a p53-independent manner [35].
To support these results, another set of A549 cells
were infected with the broad set of viruses for 24 hpi
and variations of endogenous p21, Bax and Bcl-XL
mRNA expressions and protein levels were analyzed in
parallel by RT-qPCR and western blot, respectively
(figure 5A, B and 5C). For p21, the mRNA level was
significantly reduced only in H5N1-infected samples
(p < 0.05, mRNA ratio around 0.2), while the protein
levels were reduced in cells infected by almost all the
viruses studied (figure 5A). Moreover, a down-regulation
of Bax expression was also clearly observed with signifi-
cantly reduced mRNA levels in all infected cells, despite
Figure 4 A. Validation of microarray data by RT-qPCR.T h e
measured ratio change of p53 mRNA levels was subject to statistical
analysis (student t-test, *** p-value < 0.001). B. p53 protein levels
revealed by western blot. C. Relative protein levels (RPL) measured
by densitometry analysis.
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also confirmed the down-regulation of Bcl-XL expres-
sion in cells infected by all viruses except H1N1 SOIV
and H5N2 (figure 5C). At the protein level, Bcl-XL pro-
tein level was decreased by most viruses. Of note, the
down-regulation of the three p53-target genes, p21,
BAX and Bcl-XL, was considerably greater in the
context of H5N1 infection than with the other influenza
A viruses.
Altogether, our results reveal that influenza A infec-
tion leads to the down-regulation of several p53 tran-
scriptional targets, at both the mRNA and protein levels
Figure 5 Validation of microarray data by RT-qPCR and western blot: p53 target genes, (A) p21, (B) Bax, (C)Bcl-XL. (*, ** and ***
correspond to p-values <0.05, <0,005, <0.001, respectively).
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levels common for all viruses.
p53 contributes to an antiviral cellular state
We then wished to assess whether such a global down-
regulation of the p53 pathway could be associated with
a functional effect with regards to viral replication. For
this, we compared the production yield of one represen-
tative influenza virus (subtype H3N2, circulating strain
A/Moscow/10/99) in the HCT116 isogenic cell models
(figure 6). HCT116 p53+/+ and p53-/- cells were
infected with H3N2 at a MOI of 10-3 and the released
viral genome copies were extracted from culture super-
natants and quantified by RTqPCR at 24 and 48 hpi, as
described in materials and methods. The number of
genome copies reflecting viral production was 10 and
100 fold higher in HCT116 p53-/- than in HCT116 p53
+/+ cells at 24 and 48h post-infection, respectively.
These results show the effectiveness of p53 protein at
slowing down viral production. In agreement with pre-
vious reports [6,25], these data suggest the contribution
of the p53 protein and associated pathways to the gen-
eral cellular antiviral response against influenza infection
and support the hypothesis that the virally induced glo-
bal down-regulation of the p53 pathway leads to a cellu-
lar state which favours their replication.
Discussion
A pathway of interest to study influenza interactions with
the host cell
In this present study, we report a microarray analysis
revealing that infection by four human or avian influ-
enza viruses (H3N2, H5N1, H5N2 and H7N1) signifi-
cantly alters the gene expression of several host factors
belonging to the p53 pathway. This pathway is com-
posed of numerous genes, the protein products of which
have a direct impact on host cell homeostasis, via the
regulation of cell death and cell cycle progression as
well as several other processes such as metabolism or
the cellular immune response [23]. The transcriptional
activity of p53 is tightly regulated by Hdm2 in response
to several intracellular signalling cascades triggered by
different stimuli (DNA damage, UV irradiation and
hypoxia). The central core of the pathway includes the
p53 protein itself, which can directly or indirectly shut
down the growth of stressed cells mainly by inducing
cell-cycle arrest and apoptosis. Considering the central
role of the p53 pathway, the impact of influenza infec-
tion on this cellular pathway is of particular interest.
Several studies have underlined the interplay between
influenza viruses and different cellular signalling path-
ways, such as the PI3K/Akt, innate immune or apoptotic
signalling pathways [4,36-39]. Intriguingly however, only
a few have been dedicated to changes in p53 upon influ-
enza infection, highlighting the need to further charac-
terize the interplay between influenza viruses and the
p53 pathway [25,26,34,40].
Influenza infection is associated with a global down-
regulation of signalling cascades both upstream and
downstream of p53 protein
We first observed that upstream signals of the p53 path-
w a yt h a td i r e c t l yc o n n e c ts t r e s s( U V ,h y p o x i a ,D N A
damage) -induced signalling cascades to regulators of
p53, were generally down-regulated at the transcrip-
tional level by infection. Among such regulating kinases,
DNA-PK, Chk2, JNK1 and Gsk3b genes are all under-
expressed following infection.
Similarly, our results also revealed a significant
decrease in gene expression for several endogenous p53
transcriptional targets, including p21, 14-3-3, PERP,
FAS, DR4/5, PIG3, BAX, Bcl-XL, PAI-1 and PCNA dur-
ing infection by our set of viruses. Moreover, these
results were confirmed at the protein level for p21, Bax
and Bcl-XL.
Altogether, our results indicate a global down-regula-
tion in the mRNA expression of principal factors
belonging to both upstream and downstream parts of
the p53 pathway, suggesting a global negative effect on
p53 pathway activity.
Discrepancy between p53 mRNA, protein levels and
activity in influenza infected cells
The down-regulation of p53-target genes suggests that
p53 expression and consequently its transcriptional
activity is decreased during infection. We verified
whether this was the case using luciferase assay and the
monitoring of p53 phosphorylation status by western
Figure 6 Comparison of viral titres (copies M/mL) produced in
HCT116 p53 +/+ or -/- infected with H3N2 A/Moscow/10/99,
calculated by RT-qPCR of M genome copies released in the
supernatants.
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revealed some discrepancies. On the one hand, no sig-
nificant change in p53 mRNA expression was detected
in infected cells, except for a significant decrease with
H5N1. On the other hand, levels of p53 protein expres-
sion were significantly increased by all the viruses, see-
mingly incoherent with the reduced activity of p53 in
infected cells.
Altogether, these results suggest a likely complex reg-
ulation of TP53 expression during infection. Regulating
factors include transcriptional activators (ISGF3 PRKCδ,
HOXA5, CREBPB), inhibitors (BCL6, RBPJ) and stabiliz-
ing factors (ELAVL1 and ZMAT3) [33]. Influenza infec-
tion might therefore induce the over-expression of both
inhibitors (BLC6 and RBPJ) and activators (ISGF3) (data
not shown). In accordance with this notion, a recent
study reported the stress-induced regulation of p53
activity through the control of p53 mRNA stabilization
and translation in addition to the well-described altera-
tion of protein stability [33]. Other stabilizing/destabiliz-
ing factors, such as host microRNAs may also be
involved and should be investigated in the context of
infection [33], in particular with H5N1, which induces a
down-regulation of p53 mRNA expression unlike the
other viruses.
Our results also clearly reveal that the impact that
influenza viruses have on p53 is not exclusively on gene
expression. Further investigations are necessary, in parti-
cular on the stabilization and activation of p53 protein,
considering the putative interaction of p53 with viral
proteins during the time-course of infection.
In this perspective, a recent study reported that the
viral protein NS1 interacts with p53 and inhibits its
activity [27]. Furthermore, transient expression of H5N1
NS1 (wild-type or with mutations in regions 80-84 and
92) reduced the transcriptional activity of p53 [41]. We
can hypothesize that p53 protein is stabilized upon
infection in an inactive form through interaction with
the viral NS1 protein [27]. Such a scenario would
explain our seemingly contradicting results concerning
p53 expression and activity. This may even reflect what
happens with a number of DNA viruses for which viral
proteins like BZLF1 (Epstein Barr Virus) or HBx (Hepa-
titis B virus) inhibit the transcriptional activity of a sta-
bilized form of p53 [42,43]. Interestingly, the disruption
of p53 signalling to p21 was described in human lung
A549 cells in the case of BZLF1 viral protein [44].
Viral down-regulation of the p53 pathway and
modulation of the cell cycle and apoptosis by influenza A
infection
We report the down-regulation of the p53-target genes
p21 (G1/S-arrest) and 14-3-3 (G2/M-arrest by sequester-
ing Cdc2-complex Cyclin B), both of which are involved
in cell cycle control. As expected, the down-regulation
of p21 and 14-3-3 in association with an over-expression
of the cell-cycle regulators TP53INP1 and GADD45G
[35,45], could modulate cell cycle progression and
resulted in G1-arrest. Our results are in line with one
recent study describing the effect of influenza A infec-
tion on the cell cycle and show that viruses can induce
an arrest in G0/G1 [46]. They also suggest a putative
involvement of p21, TP53INP1 and Gadd45gamma in
the influenza-induced cell cycle arrest. A thorough func-
tional evaluation of these results is now needed which
should contribute to a better understanding of the viral
mechanisms involved which permit an optimal viral pro-
tein expression and progeny production.
The other group of down-regulated p53-target genes
that we identified during infection encodes the pro-
apoptotic proteins PERP [47], Fas, DR4/5, PIG3 and
BAX. In addition, the Bax-inhibiting[48] anti-apoptotic
factor Bcl-XL, was also under-expressed during infec-
tion, as was PAI-1 whose role in regulating apoptosis
remains unclear [49]. At the protein level, Bcl-XL
expression was decreased by most viral infections. It is
worth noting that the down-regulation of the three p53-
target genes, p21, BAX and Bcl-XL, was considerably
greater after H5N1 infection than with the other influ-
enza A viruses tested.
Concordantly, the knock-down of BAX was recently
shown to reduce the replication of influenza virus [50].
Thus the down-regulation of a negative regulator of
Bax, such as the anti-apoptotic Bcl-XL, at both mRNA
and protein levels, such as we have reported here, would
be expected to increase viral replication. Further silen-
cing experiments are required to confirm such a result.
Altogether, our observations suggest that influenza
viruses may at least partially control intrinsic and extrin-
sic pathways of apoptosis by decreasing the expression
of both pro- and anti-apoptotic factors which are under
the control of the p53 transcription factor, as suggested
by several studies [39].
Is inhibition of the p53 pathway essential for the
replication cycle of influenza viruses?
In agreement with the above hypothesis, we showed
that the level of H3N2 viral production is significantly
higher in HCT116 p53 -/- than in HCT116 p53 +/+
cells, at both 24 and 48 hpi (figure 6). These results
are in accordance with initial observations reported by
Turpin and colleagues in a p53 dominant-negative
A549 model and more recent data reported on siRNA
high-throughput screening for host functional interac-
tants [25,6].
These and our results suggest a marked antiviral facet
for p53 and its pathway in the context of influenza
infection, as has already been observed for several other
Terrier et al. Virology Journal 2011, 8:285
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Page 9 of 11viruses. The antiviral effect of p53 depends largely on its
pro-apoptotic activity, which limits virus replication
[51]. However, other works have also demonstrated that
p53 contributes to the innate cellular antiviral response
by enhancing type I interferon (IFN)-dependent antiviral
activity, independently of its function as a pro-apoptotic
gene [52]. In light of our results on p53 targets impli-
cated in cell-cycle regulation and a recent study on
human circulating leukocytes from infected patients
[53], the p53 antiviral role might involve not only its
activity in mediating the IFN response and apoptosis,
but also in controlling cell cycle progression.
Conclusions
In conclusion, the p53 pathway is inhibited during infec-
tion by influenza A, either by the control over the
expression of key p53 stabilizing factors, as is the case
with H3N2, H5N1, H5N2 and H7N1, or by the decrease
in p53 mRNA levels as is the case with H5N1. In accor-
dance with an overall decrease of p53 activity, the global
down-regulation of p53-target genes could contribute to
changes in both the apoptotic response and cell-cycle
progression, altogether inducing a pro-viral cellular con-
text. The present study has highlighted the p53 pathway
as an important player in influenza infection. Further
investigations are now needed to discriminate the cellu-
lar antiviral response from the viral hijacking of the p53
pathway during the time-course of infection.
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